Libidon 20mg
An oral animal-derived prostate peptide bioregulator investigated for lower urinary tract function and prostate tissue homeostasis.
Mechanism
Proposed to operate via peptide-mediated cellular regulation, directly supporting epithelial and smooth-muscle tissue homeostasis within the prostate and lower urinary tract.
Dosing
Standard investigational protocols detail an oral starting regimen of 20 mg (one capsule) daily over a defined 10 to 30 day cycle.
Reconstitution
Oral formulation requiring no bacteriostatic water or liquid dilution prior to research administration.
Storage
Store sealed capsules in a dry, dark, climate-controlled space at room temperature away from excessive heat.
Mix & measure Libidon 20mg
Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.
Mix & measure Libidon 20mg
Vial strength → BAC water → target dose
Common vial sizes
Label claim
Total doses in vial: —
U-100 syringe: 100 units = 1 mL
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →
Track my protocol
Log each dose, build a streak, and watch your progress through this protocol's schedule.
Dosing Chart
| Phase / Day(s) | Dose & Frequency | Volume (U-100 units / mL) |
|---|---|---|
| Initiation (Days 1–10) | 20 mg once daily | 1 Oral Capsule |
| Standard Course (Days 11–30) | 20–40 mg once daily | 1–2 Oral Capsules |
| Maintenance / Interval | Course cessation for 2–4 months | None |
Reconstitution Steps
- 1
Verify capsule integrity and packaging seal prior to protocol initiation.
- 2
Bypass liquid reconstitution; no bacteriostatic water or diluent is required for this oral complex.
- 3
Measure dosing requirements on a per-capsule basis (20 mg per unit).
- 4
Store remaining capsules in a sealed, dry container protected from direct light.
Supplies Needed
Peptide Vial
Supplies the standardized 20 mg oral prostate peptide complex capsules.
Insulin Syringes (U-100)
Not applicable for this protocol as Libidon is delivered orally.
Bacteriostatic Water
Not required since the compound is an oral capsule rather than a lyophilized powder.
Alcohol Swabs
Used for sanitizing work surfaces and container exteriors during laboratory handling.
Why researchers study it
Investigation of prostate tissue integrity
Bladder and prostatic smooth-muscle contractility
Cellular homeostasis during male reproductive aging
Comparative analysis against defined prostate extracts
These describe what is being studied, not proven benefits, approved uses, or promised results.
Overview
Libidon (designated A-16) is a natural prostate bioregulator belonging to the Cytomax family of peptide complexes. Purified from bovine or porcine prostate tissue, it represents a heterogeneous collection of short-chain peptides believed to interact with cellular regulatory mechanisms in homologous tissue types. While marketed extensively across Eastern Europe as a parapharmaceutical for male reproductive support, much of the underlying scientific literature stems from defined pharmaceutical counterparts such as Prostatilen or synthetic tripeptides like Prostamax. Laboratory interest centers on assessing whether oral extracts can influence prostate cellular integrity and smooth muscle contractile tone. Unlike traditional synthetic research peptides, Libidon is administered entirely as an oral solid dose. It bypasses reconstitution processes, functioning within experimental protocols focused on cyclic, pulse-dosed physiological maintenance models.
References
- 1.Khavinson, Neuroendocrinology Letters, 2002 — Peptides and ageing
- 2.Al'-Shukri et al., Khirurgiia, 1999 — Influence of prostatilen on smooth-muscle organ activity in surgical patients
- 3.Boiko, Likars'ka Sprava, 1995 — Validation of prostatilen and testilin for treating male infertility
- 4.Khavinson et al., Advances in Gerontology, 2013 — Peptide bioregulators: a new class of geroprotectors (clinical studies results)
Supplies Needed
Suggested supplier
Research use only. Listing a supplier is not an endorsement of any protocol on this site, and nothing sold there is approved for human use.
Related protocols
View all5-Amino-1MQ 10mg
Synthetic small-molecule NNMT inhibitor explored in preclinical models for cellular energy balance, NAD+ preservation, and adipocyte metabolism.
View Protocol5-Amino-1MQ 50mg
Small-molecule NNMT inhibitor studied for cellular energy regulation, adipocyte remodeling, and metabolic research.
View ProtocolTirzepatide 10mg
Dual GIP and GLP-1 receptor agonist engineered to study synergistic incretin pathways in glycemic control and energy homeostasis.
View Protocol